Tiziana Life Sciences Ltd.: Tiziana Life Sciences PLC (TLSA: NASDAQ) Clinical Improvements for 2nd SPMS Patient
Research Note Clinical Results for Second SPMS Patient NEW YORK, June 09, 2022positive clinical results for its second secondary progressive multiple sclerosis. Based on the data gathered from
Source: finanznachrichten.de